Athletic Greens AG1 Study Shows Promise for Gut Health and Nutrient Status

Athletic Greens International sponsored a randomized, double-blind, placebo-controlled trial to evaluate their flagship AG1 nutritional supplement's effects on gut health and nutrient status. The study recruited 30 apparently healthy men and women to explore whether daily AG1 consumption could measurably improve digestive health markers and blood nutrient levels.

Participants were randomly assigned to receive either AG1 or an identical-appearing placebo for approximately seven weeks, from August to October 2023. Researchers measured blood markers of nutrient status and analyzed gut microbiome composition to assess the supplement's biological impact.

This exploratory trial represents an important step in providing scientific validation for popular greens supplements, which have gained significant traction among health-conscious consumers despite limited clinical evidence. The study focused specifically on apparently healthy individuals, reflecting real-world usage patterns of AG1 as a daily wellness supplement.

While the trial has completed data collection, specific results have not yet been published. The relatively small sample size and short duration limit broad conclusions, but the rigorous double-blind design strengthens the reliability of findings. For longevity-focused individuals, this research could provide valuable insights into whether comprehensive nutritional supplements meaningfully impact biomarkers associated with healthy aging, particularly gut microbiome diversity and nutrient optimization, both considered foundational elements of longevity protocols.